GenScript Biotech Corp Reports Strong FY2025 Results as Integrated Platform Strategy and Global Execution Drive High-Quality Growth

---
GenScript Biotech Corp Reports Strong FY2025 Results as Integrated Platform Strategy and Global Execution Drive High-Quality Growth
Vote:
0 0
Previous Bairong Inc. Will Report 2025 Annual Results on March 27, 2026
Next CLEAR AND ORACLE RED BULL RACING TAKE ON 'HELMET HAIR' DURING FORMULA ONE SHANGHAI GRAND PRIX

Related News

GenScript Biotech Corporation Reports FY 2024 Results

Genscript Biotech Reports 2022 Annual Results*

GenScript ProBio and RVAC Medicines Announce Strategic Partnership for GMP Plasmid DNA Manufacturing for mRNA COVID-19 Vaccine Candidate

GenScript Biotech Earns EcoVadis Bronze Medal for the Second Consecutive Year, Ranking Above 83% of Companies

GenScript upgrades product packaging with a recyclable strategy, reducing waste by 82% and contributing to environmental sustainability

GenScript Biotech Becomes a PSCI Supplier Partner, Advancing a Sustainable Pharmaceutical Supply Chain

menu
menu